HMM to Invest 26.3 Billion Won in Paid-In Capital Increase of Affiliate HTR Theratrix; Total Investment Reaches 68 Billion Won
HMM will participate in a paid-in capital increase by its affiliate HTR Theratrix. HMM announced through a regulatory filing on the 17th that it will invest 26,311 million won. According to the filing, the investment consists of 5,262,180 common shares of HTR Theratrix. Including this investment, H

HMM will participate in a paid-in capital increase by its affiliate HTR Theratrix. HMM announced through a regulatory filing on the 17th that it will invest 26,311 million won.
According to the filing, the investment consists of 5,262,180 common shares of HTR Theratrix. Including this investment, HMM's total investment in HTR Theratrix amounts to 68,058 million won. This figure combines the paid-in capital, previous paid-in capital increase contributions, and the current investment amount.
The decision-making process has already been completed. HMM approved the investment agenda at a board meeting on the 12th. Three independent directors attended the board meeting with no absences, and the audit committee member also attended.
The investment date was recorded as November 13. However, HMM explained that this date is the scheduled payment date for the capital and may change depending on progress. In addition, the company stated that the decision on details and execution of this transaction has been delegated to the CEO, and that the disclosed details may also change depending on progress.
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.


![[Breaking] KOSPI Falls 1.97%, Slipping Below the 5,000 Mark for the First Time Since November 9](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F581419%2F479dac739b049517%2Fvariants%2Fhero.webp&w=1920&q=75)
